Estonia - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingEstonia: Vaccine Market 2024
Vaccine Market Size in Estonia
The Estonian vaccine market dropped notably to $X in 2022, falling by -26.8% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, consumption, however, recorded a resilient expansion. Over the period under review, the market attained the peak level at $X in 2021, and then reduced remarkably in the following year.
Vaccine Exports
Exports from Estonia
Vaccine exports from Estonia contracted rapidly to X kg in 2022, with a decrease of -35.7% against the year before. Overall, exports continue to indicate a pronounced curtailment. The growth pace was the most rapid in 2016 when exports increased by 375%. As a result, the exports reached the peak of X kg. From 2017 to 2022, the growth of the exports failed to regain momentum.
In value terms, vaccine exports declined sharply to $X in 2022. In general, exports, however, continue to indicate temperate growth. The pace of growth appeared the most rapid in 2015 when exports increased by 410%. Over the period under review, the exports hit record highs at $X in 2018; however, from 2019 to 2022, the exports stood at a somewhat lower figure.
Exports by Country
Latvia (X kg), Lithuania (X kg) and Taiwan (Chinese) (X kg) were the main destinations of vaccine exports from Estonia, together accounting for 90% of total exports.
From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Lithuania (with a CAGR of +43.2%), while the other leaders experienced mixed trend patterns.
In value terms, Latvia ($X), Lithuania ($X) and Taiwan (Chinese) ($X) appeared to be the largest markets for vaccine exported from Estonia worldwide, with a combined 76% share of total exports.
Taiwan (Chinese), with a CAGR of +42.6%, recorded the highest growth rate of the value of exports, among the main countries of destination over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The average vaccine export price stood at $X per ton in 2022, rising by 4.4% against the previous year. Over the period under review, the export price showed a prominent increase. The most prominent rate of growth was recorded in 2014 when the average export price increased by 166%. The export price peaked at $X per ton in 2015; however, from 2016 to 2022, the export prices remained at a lower figure.
Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while the average price for exports to the Netherlands ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Taiwan (Chinese) (+73.0%), while the prices for the other major destinations experienced more modest paces of growth.
Vaccine Imports
Imports into Estonia
In 2022, the amount of vaccines for human medicine imported into Estonia fell remarkably to X tons, declining by -23.4% against 2021. In general, imports, however, recorded a perceptible expansion. The pace of growth appeared the most rapid in 2019 when imports increased by 107% against the previous year. As a result, imports reached the peak of X tons. From 2020 to 2022, the growth of imports remained at a somewhat lower figure.
In value terms, vaccine imports reduced markedly to $X in 2022. Over the period under review, imports, however, showed resilient growth. The most prominent rate of growth was recorded in 2021 when imports increased by 136% against the previous year. As a result, imports attained the peak of $X, and then contracted sharply in the following year.
Imports by Country
Poland (X tons), France (X tons) and Belgium (X tons) were the main suppliers of vaccine imports to Estonia, with a combined 75% share of total imports. Lithuania, Hungary and the Netherlands lagged somewhat behind, together accounting for a further 24%.
From 2012 to 2022, the biggest increases were recorded for Lithuania (with a CAGR of +51.9%), while purchases for the other leaders experienced more modest paces of growth.
In value terms, Belgium ($X) constituted the largest supplier of vaccines for human medicine to Estonia, comprising 57% of total imports. The second position in the ranking was taken by France ($X), with a 13% share of total imports. It was followed by Poland, with a 13% share.
From 2012 to 2022, the average annual growth rate of value from Belgium stood at +13.1%. The remaining supplying countries recorded the following average annual rates of imports growth: France (+13.2% per year) and Poland (+3.2% per year).
Import Prices by Country
In 2022, the average vaccine import price amounted to $X per ton, dropping by -7.1% against the previous year. Overall, the import price, however, showed noticeable growth. The most prominent rate of growth was recorded in 2021 when the average import price increased by 86% against the previous year. As a result, import price reached the peak level of $X per ton, and then contracted in the following year.
There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Belgium ($X per ton), while the price for Poland ($X per ton) was amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Latvia (+15.4%), while the prices for the other major suppliers experienced more modest paces of growth.
Source: IndexBox Platform
This report provides an in-depth analysis of the vaccine market in Estonia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202140 -
- Prodcom 21202145 - Vaccines for human medicine
Country coverage:
- Estonia
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Estonia
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the vaccine market in Asia.
This report provides an in-depth analysis of the vaccine market in the U.S..
This report provides an in-depth analysis of the vaccine market in China.
This report provides an in-depth analysis of the vaccine market in the EU.
This report provides an in-depth analysis of the global vaccine market.